← back to search

Chirag Shah

Indiana University School of Medicine · US
Area of research
Cancer Research · Radiation
Research interest
Research interests include Medicine, Breast cancer, Radiation therapy, Lymphedema, Randomized controlled trial, and Internal medicine.
h-index
citations
548
works
16
NIH funding
primary concept
email

Recent publications

Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial
Practical Radiation Oncology 2023cited by 12position: middledoi
Race and ethnicity reporting by US federal standards in high-impact phase 2/3 oncology clinical trial publications.
Journal of Clinical Oncology 2023cited by 1position: lastdoi
A Comparison of Bioimpedance Spectroscopy or Tape Measure Triggered Compression Intervention in Chronic Breast Cancer Lymphedema Prevention
Lymphatic Research and Biology 2022cited by 59position: lastdoi
Risk factors for breast cancer–related lymphedema in patients undergoing 3 years of prospective surveillance with intervention
Cancer 2022cited by 54position: middledoi
Partial breast irradiation: An updated consensus statement from the American brachytherapy society
Brachytherapy 2022cited by 41position: middledoi
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines
Breast Cancer Research and Treatment 2022cited by 38position: firstdoi
A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics 2022cited by 34position: middledoi
The economic impact of circulating tumor-tissue modified HPV DNA for the post-treatment surveillance of HPV-driven oropharyngeal cancer: A simulation
Oral Oncology 2022cited by 18position: lastdoi
Reducing rates of chronic breast cancer–related lymphedema with screening and early intervention: an update of recent data
Journal of Cancer Survivorship 2022cited by 14position: lastdoi
Abstract P3-17-03: Raising the level of cancer care around the world: The feasibility and perceived benefit of a virtual breast tumor board
Cancer Research 2022cited by 0position: middledoi
Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
Cancers 2021cited by 51position: middledoi
US Radiation Oncologists (Re)Defined: An American Society for Radiation Oncology Scope of Practice Study
International Journal of Radiation Oncology*Biology*Physics 2020cited by 18position: middledoi
Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics 2016cited by 90position: middledoi
Cost-comparativeness of proton versus photon therapy
Chinese Clinical Oncology 2016cited by 68position: middledoi
Hypofractionated regional nodal irradiation for breast cancer: Examining the data and potential for future studies
Radiotherapy and Oncology 2014cited by 37position: middledoi
Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation
Cancer 2012cited by 13position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2012–2023)Pat W. Whitworth · The University of Texas Southwestern Medical Center4 papers (2021–2022) · 3 papers (2014–2023)G. Bruce Mann · Amgen (United States)2 papers (2021–2022) · 2 papers (2022–2022)Stephanie A. Valente · Cleveland Clinic Lerner College of Medicine2 papers (2022–2022) · 2 papers (2022–2022)John Boyages · Australian National University2 papers (2022–2022)Michael Hughes · Australian National University2 papers (2022–2022) · 2 papers (2022–2023)Douglas W. Arthur · Virginia Commonwealth University2 papers (2014–2022)James French · Cancer Institute of New South Wales2 papers (2022–2022)Nicholas Ngui · Australian National University2 papers (2022–2022)Mary S. Dietrich · The Ohio State University2 papers (2022–2022)Matthew M. Poppe · University of Utah2 papers (2014–2023) · 2 papers (2022–2022)Jeremy Hsu · The University of Sydney2 papers (2022–2022)Louise Koelmeyer · Macquarie University2 papers (2022–2022)Sheila Weinmann · University of Vermont2 papers (2021–2022)Troy Bremer · University of Massachusetts Chan Medical School2 papers (2021–2022)